Treace Medical Concepts ( (TMCI) ) has issued an update.
Treace Medical Concepts has initiated a lawsuit against Stryker Corporation for patent infringement and unfair competition, highlighting its commitment to protecting its pioneering bunion correction technology. The company maintains its financial outlook, anticipating a 50% improvement in Adjusted EBITDA for 2024 and achieving breakeven by 2025. This legal action underscores Treace’s dedication to safeguarding its innovations in the foot and ankle market.
Find detailed analytics on TMCI stock on TipRanks’ Stock Analysis page.
